Published Date: Fri, Aug 28, 2026
The Oct. 1 HealthHelp transition for genetic/molecular lab testing prior auth review is fast approaching for providers in Delaware, Pennsylvania, and West Virginia.
Note: The start date for New York providers to begin using HealthHelp is moving to later in the year. We will share additional information about the new effective date when it becomes available.
As a reminder, Highmark is engaging HealthHelp, a specialty benefit management company, to assist Highmark in applying evidence-based medical criteria and expert peer consultation to ensure appropriate utilization of molecular lab services.
This transition will apply to your Highmark commercial fully insured, Medicare Advantage, ACA, self-funded Administrative Services Only (ASO) (for DE, PA, and WV only), and Pennsylvania Child Health Insurance Program (CHIP) patients.
Quick Info
Never miss out on what matters. Subscribe to our emails and stay informed.